ADCC responses and blocking of EGFR-mediated signaling and cell growth by combining the anti-EGFR antibodies imgatuzumab and cetuximab in NSCLC cells
Arjan Kol(University Medical Center Groningen), Steven de Jong(University Medical Center Groningen)
Cited by 31
Related Papers
MAPK pathway activity plays a key role in PD‐L1 expression of lung adenocarcinoma cells
|The Journal of Pathology|2019|163
Differential modulation of the TRAIL receptors and the CD95 receptor in colon carcinoma cell lines
|British Journal of Cancer|2003|62
Low-dose triple drug combination targeting the PI3K/AKT/mTOR pathway and the MAPK pathway is an effective approach in ovarian clear cell carcinoma
|Cancer Letters|2019|58
Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma
|Clinical Cancer Research|2018|52
‘Big’-Insulin-Like Growth Factor–II Signaling Is an Autocrine Survival Pathway in Gastrointestinal Stromal Tumors
|American Journal Of Pathology|2012|18